Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJet2 Regulatory News (JET2)

Share Price Information for Jet2 (JET2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,340.00
Bid: 1,342.00
Ask: 1,346.00
Change: 2.00 (0.15%)
Spread: 4.00 (0.298%)
Open: 1,334.00
High: 1,348.00
Low: 1,324.00
Prev. Close: 1,338.00
JET2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid Corporate Financing Facility

12 Mar 2021 11:15

RNS Number : 1216S
Jet2 PLC
12 March 2021
 

12 March 2021

Jet2 plc ("Jet2", the "Group" or the "Company")

 

Covid Corporate Financing Facility

 

On 14 May 2020, the Company announced that it was confirmed as an eligible issuer under the Bank of England's Covid Corporate Financing Facility ("CCFF"). In October 2020, Her Majesty's Treasury ("HMT") amended the CCFF eligibility requirements to include, amongst other criteria, an updated investment grade requirement to reflect the impact of the pandemic. As a result, HMT has conducted a review process with the Company to ascertain whether it remains eligible for the CCFF.

With that process now complete, we are pleased to announce that Jet2 plc has been re-confirmed as an eligible issuer for the CCFF for up to £200m. The Company intends to issue the full amount of commercial paper through the CCFF prior to the closure of the scheme on 22 March 2021, which will be used to provide standby liquidity if required. 

 

Philip Meeson, Executive Chairman, commented:

"The Group is grateful to both the Bank of England and HM Treasury for the CCFF, the ongoing provision of the Coronavirus Job Retention Scheme and, together with the responsible liquidity actions already taken by the business, this provides the Group with additional headroom to deal with the ongoing cost of disruption to our sector, ensuring we can continue to support our great business through this challenging period.

 

Our liquidity position is strong - the Group's cash position as at 7 March 2021 (with the CCFF undrawn) comprised unaudited Total Cash of £1,189m and "Own Cash" of £892m (excluding advance customer deposits), having already proactively returned over £1.2bn of customer deposits since the start of the pandemic.

 

We have recently experienced a notable increase in bookings for Summer 2021 in line with the more recent positive news and though still early, we continue to be encouraged by the volume of our customer bookings for both Winter 21/22 and Summer 2022. Based on this limited visibility, we are confident that once normality returns, our Customers will be determined to enjoy the wonderful experience of a well-deserved Jet2 holiday and that Jet2.com and Jet2holidays will continue to have a thriving future, taking millions of UK holidaymakers annually, to the Mediterranean, the Canary Islands and to European Leisure Cities."

 

For further information, please contact:

 

Jet2 plc

Philip Meeson, Executive Chairman

Tel: 0113 239 7692

Gary Brown, Group Chief Financial Officer

Cenkos Securities plc - Nominated Adviser

Katy Birkin/Russell Cook

Tel: 020 7397 8900

Canaccord Genuity - Joint Broker

Adam James

Tel: 020 7523 8000

Jefferies International Limited - Joint Broker

Ed Matthews

Tel: 020 7029 8000

Buchanan - Financial PR

Richard Oldworth

Tel: 020 7466 5000

 

Certain of the information communicated in this announcement would have been deemed inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time, until the release of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKBBDDBKDNND
12
Date   Source Headline
24th Apr 20247:00 amRNSTrading Update
15th Apr 20241:36 pmRNSHolding(s) in Company
28th Mar 20244:30 pmRNSBlocklisting Interim Review and TVR
13th Mar 20247:00 amRNSDirectorate Changes
16th Feb 20241:17 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Update
1st Feb 20248:20 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSHolding(s) in Company
16th Jan 20247:00 amRNSDirector/PDMR Shareholding
15th Dec 20234:25 pmRNSHolding(s) in Company
15th Dec 20232:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSInterim Results
1st Nov 20231:30 pmRNSChange of Nominated Adviser
2nd Oct 20233:00 pmRNSHolding(s) in Company
2nd Oct 20237:00 amRNSBlocklisting Interim Review & Total Voting Rights
21st Sep 202311:33 amRNSAdjustment of Convertible Bond Conversion Price
8th Sep 20237:00 amRNSGrant of Options under Sharesave scheme
8th Sep 20237:00 amRNSResult of AGM
7th Sep 20237:00 amRNSAnnual General Meeting Statement
5th Sep 20237:00 amRNSDirectorate Change
7th Aug 20234:20 pmRNSPosting of Annual Report and Notice of AGM
18th Jul 202312:33 pmRNSDirector/PDMR Shareholding
17th Jul 20233:09 pmRNSDirector/PDMR Shareholding
13th Jul 20232:30 pmRNSDirector/PDMR Shareholding
11th Jul 20238:03 amRNSHolding(s) in Company
6th Jul 20237:01 amRNSDirectorate Change
6th Jul 20237:00 amRNSFinal Results
16th May 20235:00 pmRNSUpdate on UK ownership and Permitted Maximum
20th Apr 20237:00 amRNSTrading Update
14th Apr 202310:06 amRNSDirectorate Changes
31st Mar 20237:00 amRNSBlocklisting Interim Review & Total Voting Rights
2nd Feb 202312:52 pmRNSHolding(s) in Company
26th Jan 20237:00 amRNSTrading Update
1st Dec 20222:41 pmRNSDirector/PDMR Shareholding
25th Nov 202210:12 amRNSDirector/PDMR Shareholding
25th Nov 20227:00 amRNSDirector/PDMR Dealing
24th Nov 20227:00 amRNSHalf-year Report
19th Oct 20225:00 pmRNSNew Revolving Credit Facility
18th Oct 20227:00 amRNSAircraft Order
3rd Oct 202211:07 amRNSBlocklisting Interim Review & Total Voting Rights
2nd Sep 20223:11 pmRNSGrant of Options and Director/PDMR Shareholding
1st Sep 202212:30 pmRNSResult of AGM
1st Sep 20227:00 amRNSAnnual General Meeting Statement
8th Aug 20224:01 pmRNSPosting of Annual Report & Accounts
29th Jul 20224:30 pmRNSTotal Voting Rights
20th Jul 20224:00 pmRNSGrant of Options and Vesting of Deferred Awards
12th Jul 202210:51 amRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 202211:16 amRNSDirector/PDMR Shareholding
8th Jul 202211:15 amRNSDirector/PDMR Shareholding
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.